InvestSMART

VanEck Global Healthcare Leaders ETF (ASX: HLTH) - Announcements

Current share price for HLTH : $10.740 0.12 (1.10%)

VanEck Global Healthcare Leaders ETF (HLTH) gives investors exposure to a diversified portfolio of the largest international companies from the global healthcare sector. HLTH aims to provide investment returns before fees and other costs which track the performance of the Index.

Latest company announcements for VanEck Global Healthcare Leaders ETF (HLTH)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$55 Issued Units Outstanding as at 31 March 2024 3 Apr 2024 8:27AM $11.430 $10.740 $10.960 fallen by 6.04%
$55 Half-Year Financial Report 14 Mar 2024 3:21PM $11.290 $10.740 $10.960 fallen by 4.87%
$55 Indicative dividends calendar for 2024 5 Mar 2024 6:07PM $11.240 $10.740 $10.960 fallen by 4.45%
$55 Issued Units Outstanding as at 29 February 2024 5 Mar 2024 5:56PM $11.240 $10.740 $10.960 fallen by 4.45%
$55 Issued Units Outstanding as at 31 January 2024 2 Feb 2024 12:01PM $10.910 $10.740 $10.960 fallen by 1.56%
$55 Issued Units Outstanding as at 31 December 2023 2 Jan 2024 11:04AM $10.350 $10.740 $10.960 risen by 3.77%
$55 Issued Units Outstanding as at 30 November 2023 5 Dec 2023 8:14AM $9.980 $10.740 $10.960 risen by 7.62%
$55 Issued Units Outstanding as at 31 October 2023 1 Nov 2023 2:22PM $9.680 $10.740 $10.960 risen by 10.95%
$55 Issued Units Outstanding as at 30 September 2023 3 Oct 2023 5:18PM $10.090 $10.740 $10.960 risen by 6.44%
$55 Annual Report FYE 30 June 2023 29 Sep 2023 9:55AM $10.120 $10.740 $10.960 risen by 6.13%
$55 Issued Units Outstanding as at 31 August 2023 1 Sep 2023 4:24PM $10.450 $10.740 $10.960 risen by 2.78%
$55 Issued Units Outstanding as at 31 July 2023 1 Aug 2023 1:50PM $10.330 $10.740 $10.960 risen by 3.97%
$55 Dividend component details 17 Jul 2023 8:24AM $9.910 $10.740 $10.960 risen by 8.38%
$55 Dividend Reinvestment Plan Prices 3 Jul 2023 5:15PM $10.160 $10.740 $10.960 risen by 5.71%
$55 Issued Units Outstanding as at 30 June 2023 3 Jul 2023 5:15PM $10.160 $10.740 $10.960 risen by 5.71%
$55 Final Dividend/Distribution for period ending 30 June 2023 30 Jun 2023 8:20AM $10.250 $10.740 $10.960 risen by 4.78%
$55 Dividend timetable 22 Jun 2023 8:34AM $10.210 $10.740 $10.960 risen by 5.19%
$55 Issued Units Outstanding as at 31 May 2023 1 Jun 2023 3:23PM $10.370 $10.740 $10.960 risen by 3.57%
$55 Issued Units Outstanding as at 30 April 2023 1 May 2023 3:41PM $10.790 $10.740 $10.960 fallen by 0.46%
$55 Issued Units Outstanding as at 31 March 2023 4 Apr 2023 9:55AM $10.560 $10.740 $10.960 risen by 1.70%
$55 Half-Year Financial Report 13 Mar 2023 9:09AM $10.290 $10.740 $10.960 risen by 4.37%
$55 Issued Units Outstanding as at 28 Feb 2023 2 Mar 2023 1:21PM $10.150 $10.740 $10.960 risen by 5.81%
$55 Number of Outstanding Units as at 31 January 2023 1 Feb 2023 3:36PM $10.230 $10.740 $10.960 risen by 4.99%
$55 Indicative dividends calendar for 2023 11 Jan 2023 9:25AM $10.380 $10.740 $10.960 risen by 3.47%
$55 Number of Outstanding Units as at 31 December 2022 3 Jan 2023 4:06PM $10.480 $10.740 $10.960 risen by 2.48%

1 - 25 of 64 results

Page 1 of 3

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.